Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Toxicol Clin Toxicol ; 39(5): 447-52, 2001.
Article in English | MEDLINE | ID: mdl-11545234

ABSTRACT

OBJECTIVE: Although intentional and unintentional rodenticide poisoning is common, most readily available agents are of relatively low acute toxicity. A four-year long epidemic of severe toxicity from rodenticide exposure continues among patients predominantly of Dominican descent living in New York City. This study characterizes the ongoing epidemic of acute cholinesterase inhibitor poisoning due to an illicit rodenticide and identifies its etiology. METHODS: A prospectively collected case series of poisoned patients referred to the New York City Poison Control Center. The main outcome measures include the clinical characteristics upon presentation, antidotal and other therapeutic requirements, and patient outcome. Product analysis was performed with paper chromatography, gas chromatography/mass spectrometry, and high-performance liquid chromatography. A murine model assessing both clinical effect and cholinesterase activity was also performed. RESULTS: Thirty-five patients were referred following exposure to Tres Pasitos. Patients developed signs of cholinergic hyperactivity and many required high doses of atropine (>10 mg) to control these symptoms. The source was identified as a rodenticidal compound sold illicitly in local groceries primarily within the Dominican community. Murine cholinesterase activity fell significantly following exposure to the rodenticide. High-performance liquid chromatography identified aldicarb, an extremely potent carbamate-type cholinesterase inhibitor, not licensed for rodenticidal use in this country. CONCLUSION: Illicit sale of undocumented compounds poses a substantial public health threat. Despite several public health interventions, the epidemic continues.


Subject(s)
Aldicarb/poisoning , Rodenticides/poisoning , Adolescent , Adult , Animals , Atropine/therapeutic use , Cholinesterase Inhibitors/poisoning , Cholinesterase Reactivators/therapeutic use , Chromatography, High Pressure Liquid , Chromatography, Paper , Disease Outbreaks , Gas Chromatography-Mass Spectrometry , Humans , Infant , Male , Mice , New York City , Pralidoxime Compounds/therapeutic use , Prospective Studies , Treatment Outcome
2.
Ann Emerg Med ; 24(6): 1108-14, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7978592

ABSTRACT

STUDY OBJECTIVES: To determine which adult patients with new-onset seizures require admission and whether those who require admission can be identified in the emergency department. DESIGN: Retrospective chart review of patients seen during a 5-year period. SETTING: Urban county teaching hospital in southern California. PARTICIPANTS: Three hundred thirty-three adult patients with new-onset seizures. Patients were excluded if they had acute head trauma, hypoglycemia from diabetic therapy, or alcohol- or recreational drug-related seizures. INTERVENTIONS: Standardized medical evaluation including physical examination, CBC, SMA-7 (electrolytes, blood urea nitrogen, creatinine, glucose), calcium, cranial computed tomography (CT), lumbar puncture if indicated, and admission to the hospital. RESULTS: Forty-six percent of patients (136 of 294) admitted to our hospital required admission as judged by a retrospective evaluation of the ED and hospital course. The numbers of patients who had a clinically significant result with each part of the evaluation were: physical examination, 75 of 333 (23%); CBC, 25 of 319 (8%); SMA-7, 21 of 329 (6%); calcium, 2 of 208 (1%); CT, 134 of 325 (41%); and lumbar puncture, 19 of 227 (8%). Ninety-five percent of patients requiring admission (129 of 136) were detected by the standardized medical evaluation. CONCLUSION: One half of patients with new-onset seizures require admission. Patients with new-onset seizures who require admission can usually be detected by a standardized medical evaluation in the ED.


Subject(s)
Emergency Service, Hospital/standards , Patient Admission/standards , Seizures/etiology , Adolescent , Adult , Aged , Aged, 80 and over , California , Central Nervous System Diseases/complications , Central Nervous System Diseases/diagnosis , Female , Follow-Up Studies , Hospitals, Teaching/statistics & numerical data , Humans , Length of Stay , Male , Middle Aged , Neuritis/complications , Neuritis/diagnosis , Recurrence , Retrospective Studies , Status Epilepticus/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL